Publicaciones de Lorena Gonzalez

2016

  • Frequency of self-monitoring blood glucose and attainment of HbA1c target values. Elgart JF, González L, Prestes M, Rucci E, Gagliardino JJ. Acta Diabetologica. Feb; 53(1):57-62. doi: 10.1007/s00592-015-0745-9 (ISSN: 0940-5429).
  • Primary prevention of type 2 diabetes in Argentina: Pilot study in the province of Buenos Aires. Juan José Gagliardino, Graciela Etchegoyen, Marcelo Bourgeois, Gabriel Fantuzzi, Silvia García, Lorena González, Jorge Federico Elgart, Matías Ré, Alberto Ricart, Juan Pablo Ricart, Eduardo Spinedi. Revista Argentina de Endocrinología y Metabolismo 53:135-141, 2016.
  • Dapagliflozin versus Sulfonylurea as an add-on therapy to Metformin: a Cost-effectiveness analysis in Costa Rica. Elgart JF, Gonzalez L, Prestes M, Vinocour M, Solorzano J, Gagliardino JJ. ISPOR 21st International Meeting, Washington, USA. Value in Health. 2016; 19(3):A202.
  • Cost-effectiveness of Dapagliflozin in the treatment of type 2 diabetes mellitus in Peru. Elgart JF, Gonzalez L, Prestes M, Manrique H, Solorzano J, Gagliardino JJ. ISPOR 21st International Meeting, Washington, USA. Value in Health. 2016; 19(3):A203.
  • Cost of type 2 diabetes treatment in Latin America: effect of degree of metabolic control. Elgart JF, Gonzalez L, Prestes M, Gagliardino JJ. ISPOR 21st International Meeting, Washington, USA. Value in Health. 2016; 19(3):A201.
  • Dapagliflozin: Cost effectiveness as an add-on therapy to metformin in the treatment of type 2 diabetes in Ecuador. Elgart JF, Prestes M, Gonzalez L, Solis Sanchez C, Acosta W, Solorzano J, Gagliardino JJ. ISPOR 21st International Meeting, Washington, USA. Value in Health. 2016; 19(3):A202.
  • Resultados preliminares del programa piloto de prevención primaria de diabetes en la Provincia de Buenos Aires (PPDBA). Gagliardino J, Etchegoyen G, Spinedi E, Bourgeois M, Elgart J, Fantuzzi G, García S, González C, González L, Re M, Ricart A, Ricart J. XX Congreso Argentino de Diabetes, Sociedad Argentina de Diabetes (SAD). Revista de la SAD. 2016.
  • Impacto del grado de control metabólico sobre el costo del tratamiento Farmacológico de la diabetes tipo 2 en Argentina. Elgart JF, González L, Prestes M, Gagliardino JJ. XX Congreso Argentino de Diabetes, Sociedad Argentina de Diabetes (SAD). Revista de la SAD. 2016.
  • Cost-effectiveness of dapagliflozin as an add-on therapy to metformin in the treatment of type 2 diabetes (T2DM) in the Dominican Republic and Guatemala. Elgart JF, Prestes M, Gonzalez L, Solorzano J, Gagliardino JJ. ISPOR 19th Annual Europena Congress. Value in Health, 2016; 19(7):A671–A672.

2015

  • Educación de personas con diabetes tipo 2: ¿Es costo efectiva su implementación a través de pares con diabetes?. Gonzalez L, Elgart JF, Gagliardino JJ. Medwave Medwave. Dec; 15(11):e6348. doi: 10.5867/medwave.2015.11.6348 (ISSN: 0717-6384).
  • Análisis de Costo-Efectividad de la Educacion de pacientes con Diabetes Tipo 2 por Pares. Gonzalez L, Elgart JF, Prestes M, Gagliardino JJ. ISPOR 5th Latin America Conference, Santiago, Chile. Value in Health. 2015; 18(7):A864-865
  • Impacto Presupuestario de Incorporar Linagliptina para el tratamiento de la Diabetes en Argentina. Elgart JF, Prestes M, Gonzalez L, De los Santos MC, Gagliardino JJ. ISPOR 5th Latin America Conference, Santiago, Chile. Value in Health. 2015; 18(7):A863
  • Body mass index impact on treatment costs in people with type 2 diabetes in Latin America. Elgart JF, Gonzalez L, Rucci E, Gagliardino JJ. IDF World Diabetes Congress, Vancouver, Canadá.

2014

  • Calidad de atención de personas con diabetes tipo 2 en Latinoamérica: ¿hay evidencia de disparidad de género? Wandurraga EA, Villena Chávez J, Stepenka V, Solis CL, Ramirez de Peña D, Perez Manghi F, Padron MA, Manrique H, Lujan D, Lapertosa S, Gonzalez J, Fuente G, Faingold MC, Commendatore V, Aschner P, Gonzalez L, Elgart JF, Gagliardino JJ, DIFAR Academic Committee. Revista ALAD Vol 4 Nº 3. 2014.
  • Automonitoreo glucémico: utilización y costo según tipo de medicación y grado de control metabólico en la seguridad social argentina. Gonzalez Lorena; Elgart Jorge; Rucci Enzo; Prestes Mariana; Gagliardino JJ. Resumen. Congreso. XIX Congreso Argentino de Diabetes, Sociedad Argentina de Diabetes (SAD). Mar del Plata. 2014.
  • Calidad de atención de personas con diabetes tipo 2 en argentina (QUALIDIAB): ¿Prescribimos y logramos metas terapéuticas recomendadas en nuestros pacientes?. Faingold MC; Lapertosa S; Fuente G; Perez Manghi F; Gonzalez J; Commendatore V; De Carolis S; Rueda S; Urdangarin R; Sosa L; Gonzalez Lorena; Elgart Jorge; Gagliard
  • Dapagliflozin versus sulfonylurea as an add-on therapy to metformin: a cost-effectiveness analysis in Colombia. Elgart Jorge; Prestes Mariana; Gonzalez Lorena; Aschner P; Garrido Lecca S; Aiello Eleonora; Jimenez C; Gagliardino JJ. Resumen. Congreso. ISPOR 19th International Meeting. 2014.
  • Saxagliptin/metformin extended-release (xr) for the type 2 diabetes (T2DM) treatment in Venezuela: a budget impact analysis. Elgart Jorge; Gonzalez Lorena; Perez Monteverde; Garrido Lecca S; Aiello Eleonora; Gagliardino JJ. Resumen. Congreso. ISPOR 19th International Meeting, Montreal, Canadá. 2014.
  • Treatment of type 2 diabetes in Colombia: economic evaluation of Saxagliptin/Metformin extended-release (xr) fixed-dose combination (FDC). Elgart Jorge; Prestes Mariana; Gonzalez Lorena; Garrido Lecca S; Aiello Eleonora; Jimenez C. Resumen. Congreso. ISPOR 19th International Meeting, Montreal, Canadá. Value in Health. 2014.
  • Self-Monitoring of Blood Glucose: use, frequency drivers, and cost in Argentina. Jorge Elgart; Lorena Gonzalez; Enzo Rucci; Juan José Gagliardino. Journal of diabetes Science and technology California: SAGE Journals, 2014. vol. 8, n° 6, p. 1121-1125. ISSN 1932-2968
  • The Burden of Diabetes in Argentina. Gonzalez Lorena; Caporale Joaquín; Elgart Jorge; Gagliardino JJ. Global journal of health Science. Canadian Center of Science and Education, 2014. vol. 7, n° 3, p. 124-133. ISSN 1916-9736
  • Dapagliflozin: cost-effectiveness as an add-on therapy to metformin in the treatment of type 2 diabetes (T2DM) in Argentina and Chile. Elgart JF, Prestes M, Gonzalez L, Asteazaran S, Aiello E, Garrido Lecca S, Alvarez A, Roberts M, Cortes Cuadra P, Gagliardino JJ. ISPOR 19th International Meeting, Montreal, Canadá. Value in Health. 2014; 17(3):A248.

2013

  • Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina. Elgart JF, Caporale JE, Gonzalez L, Aiello E, Waschbusch M, Gagliardino JJ. Health Econ Rev. 2013 Apr 27;3(1):11.
  • Type 2 diabetes patients educated by other patients perform at least as well as patients trained by professionals. Gagliardino JJ, Arrechea V, Assad D, Gagliardino GG, González L, Lucero S, Rizzuti L, Zufriategui Z, Clark C Jr. Diabetes Metab Res Rev. 2013 Feb;29(2):152-60.
  • Clinical, metabolic and psychological outcomes and treatment costs of a prospective-randomized trial based on different educational strategies to improve diabetes care (PRODIACOR). JJ Gagliardino, S Lapertosa, G Pfirter, M Villagra, JE Caporale, CD Gonzalez, J Elgart, L González, C Cernadas, E Rucci, Ch Clark Jr, on behalf of the PRODIACOR. Diabet Med. 2013 Sep;30(9):1102-11. doi: 10.1111/dme.12230. Epub 2013 Jun 7.
  • Changes in quality of care and costs induced by implementation of a diabetes program in a social security entity of Argentina. González L, Elgart JF, Calvo H, Gagliardino JJ. Clinicoecon Outcomes Res. 2013 Jul 4;5:337-45. doi: 10.2147/CEOR.S40949. Print 2013.
  • Abatacept for the treatment of patients with rheumatoid arthritis in argentina: a cost-effectiveness analysis. Elgart JF, Gonzalez L, Aiello EC. ISPOR 18th Annual International Meeting, May 2013.
  • Self-monitoring blood glucose: strips consumption rate and costs in Argentina. Elgart JF, Gonzalez L, Rucci E, Gagliardino JJ. ISPOR 18th Annual International Meeting, May 2013.
  • Type 2 diabetes: burden of the disease and out-of-pocket expenditures in Argentina. Elgart JF, Gonzalez L, Caporale JE, De la fuente JL, Camilluci C, Gagliardino JJ. ISPOR 18th Annual International Meeting, May 2013.
  • Budget Impact Analysis of the introduction of saxagliptin/metformin extended-release (XR) in the treatment of type 2 diabetes in Chile. Elgart JF, Gonzalez L, Aiello EC, Gagliardino JJ. ISPOR 18th Annual International Meeting, May 2013.
  • Cost-effectiveness of abatacept for the treatment of patients with rheumatoid arthritis after an inadequate response to methotrexate in Chile. Elgart JF, Gonzalez L, Aiello EC. ISPOR 18th Annual International Meeting, May 2013.
  • Burden of Type 2 Diabetes and Out-of-Pocket Expenditures in Argentina. J Elgart, L González, S Asteazarán, Je Caporale, J De La Fuente, C Camillucci, JJ Gagliardino. 73rd American Diabetes Association Scientific Session. Chicago, 21-25 de junio 2013.
  • Self-Monitoring Blood Glucose: Treatment Dependence on Strip Consumption and Costs. J Elgart, L González, E Rucci, JJ Gagliardino. 73rd American Diabetes Association Scientific Session. Chicago, 21-25 de junio 2013.
  • Costo del automonitoreo glucémico en pacientes en tratamiento combinado oral y con insulina en Argentina. Elgart J; Gonzalez L; Gagliardino JJ, Rucci E. ISPOR 4th Latin American Conference. Buenos Aires, 12-14 de septiembre 2013.
  • Relación del índice de masa corporal y gasto en medicamentos en personas con diabetes en Argentina. Prestes M; Elgart J; Gonzalez L, Gagliardino JJ. ISPOR 4th Latin American Conference. Buenos Aires, 12-14 de septiembre 2013.
  • Treatment of type 2 diabetes with saxagliptin/metformin extended-release (XR): budget impact analysis in Argentina. Elgart J, Gonzalez L, Aiello EC, Gagliardino JJ. ISPOR 4th Latin American Conference. Buenos Aires, 12-14 de septiembre 2013.
  • Gasto en medicamentos en personas con diabetes según índice de masa corporal en latinoamérica. Lorena González, Mariana Prestes, Jorge Elgart, Juan José Gagliardino. XV Congreso de la Asociación Latinoamericana de Diabetes. Cancún. 12-15 de noviembre 2013.
  • Utilization rate and cost of test strips for self-monitoring blood glucose in the social security system of Argentina. Elgart JF, González L, Rucci E And Gagliardino JJ. IDF Congress, Melbourne December 2013.